SOUTH
SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024
/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX),
a clinical-stage pharmaceutical company focused on developing novel
therapies for the treatment of prostate cancer, today announced
that the Company will present at the JonesHealthcare Seaside Summit
on Monday, July 15, 2024 at
11:00 a.m. PT.
David R. Parkinson, President and
Chief Executive Officer, will host the presentation and will also
participate in a panel discussion titled "Innovations and
Challenges in Prostate Cancer" at 9:00 a.m.
PT.
A live webcast of the presentation can be accessed in the
Investors/Events & Presentations section of ESSA's website at
www.essapharma.com. Following the event, the webcast will be
archived on the ESSA website for 90 days. The panel, "Innovations
and Challenges in Prostate Cancer," will not be webcast.
About ESSA Pharma Inc.
ESSA is a clinical-stage
pharmaceutical company focused on developing novel and proprietary
therapies for the treatment of patients with prostate cancer. For
more information, please visit www.essaphrma.com, and follow us on
X and LinkedIn.
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating
Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-joneshealthcare-seaside-summit-302190883.html
SOURCE ESSA Pharma Inc